News

OptimizeRx Sales Pipeline Up 79% to $84 Million in 2019; Company Reiterates Strong Q4 and 2020 Outlook

09 December 2019

ROCHESTER, Mich., Dec. 09, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health solutions for pharmaceutical companies, payers, medtech and medical associations, reported its sales pipeline, which is comprised of outstanding request for proposals (RFPs) submitted, has increased 79% to $84 million in 2019 as compared to last year. The company’s RFPs have historically realized a 35%-50% close rate.

Read the press release here.

“The benefits of this integration have begun to appear in the growth of our aggregate pipeline, including an increase of our average deal size from $130,000 in 2018 to $300,000 in 2019.”
Steve Silvestro
CCO, OptimizeRx
BETTER CONNECTIONS. BETTER OUTCOMES.

SIGN UP FOR NEWS & UPDATES.

Stay Connected